搜索
Edgewise Therapeutics Inc
EWTX添加自选
36.810USD
+1.990+5.72%
收盘 06/18, 16:00（美东）报价延迟15分钟
3.96B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
OrbiMed Advisors, LLC
14.42%
RA Capital Management, LP
9.69%
Baker Bros. Advisors LP
6.11%
Paradigm BioCapital Advisors LP
6.08%
BlackRock Institutional Trust Company, N.A.
4.99%
其他
58.71%
持股股东
持股股东
占比
OrbiMed Advisors, LLC
14.42%
RA Capital Management, LP
9.69%
Baker Bros. Advisors LP
6.11%
Paradigm BioCapital Advisors LP
6.08%
BlackRock Institutional Trust Company, N.A.
4.99%
其他
58.71%
股东类型
持股股东
占比
Hedge Fund
26.58%
Investment Advisor
25.01%
Investment Advisor/Hedge Fund
22.62%
Private Equity
18.57%
Venture Capital
16.08%
Research Firm
4.77%
Pension Fund
0.83%
Sovereign Wealth Fund
0.70%
Individual Investor
0.46%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
423
124.09M
115.41%
-4.77M
2025Q4
387
119.80M
108.62%
--
2025Q3
392
119.88M
108.70%
-25.05K
2025Q2
397
119.92M
109.42%
+13.50M
2025Q1
381
106.67M
114.89%
-2.71M
2024Q4
360
100.40M
111.45%
-3.06M
2024Q3
330
102.86M
113.45%
-343.49K
2024Q2
288
102.77M
111.98%
+3.64M
2024Q1
262
99.10M
100.16%
+5.54M
2023Q4
235
80.75M
106.84%
+11.50M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
OrbiMed Advisors, LLC
15.52M
14.47%
--
--
Dec 31, 2025
RA Capital Management, LP
10.43M
9.72%
--
--
Dec 31, 2025
Baker Bros. Advisors LP
6.58M
6.13%
-730.00K
-9.99%
Dec 31, 2025
Paradigm BioCapital Advisors LP
6.54M
6.1%
+371.08K
+6.01%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.37M
5%
+288.25K
+5.68%
Dec 31, 2025
Novo Holdings A/S
5.35M
4.99%
--
--
Dec 31, 2025
Braidwell LP
5.21M
4.86%
--
--
Dec 31, 2025
Janus Henderson Investors
4.57M
4.26%
-412.48K
-8.28%
Dec 31, 2025
Invus Public Equities Advisors, LLC
4.53M
4.22%
+632.89K
+16.24%
Dec 31, 2025
Perceptive Advisors LLC
4.46M
4.16%
+662.08K
+17.44%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
3.27%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.09%
State Street SPDR S&P Pharmaceuticals ETF
1.71%
ALPS Medical Breakthroughs ETF
0.81%
Virtus LifeSci Biotech Clinical Trials ETF
0.8%
First Trust Multi-Manager Small Cap Opportunities ETF
0.55%
iShares U.S. Pharmaceuticals ETF
0.5%
ProShares Ultra Nasdaq Biotechnology
0.33%
Optimize Strategy Index ETF
0.26%
iShares Health Innovation Active ETF
0.25%
查看更多
iShares Neuroscience and Healthcare ETF
占比3.27%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.09%
State Street SPDR S&P Pharmaceuticals ETF
占比1.71%
ALPS Medical Breakthroughs ETF
占比0.81%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.8%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.55%
iShares U.S. Pharmaceuticals ETF
占比0.5%
ProShares Ultra Nasdaq Biotechnology
占比0.33%
Optimize Strategy Index ETF
占比0.26%
iShares Health Innovation Active ETF
占比0.25%
